Skip to main content
. 2021 Jun 2;11:600768. doi: 10.3389/fonc.2021.600768

Figure 2.

Figure 2

Nomograms for predicting 1-, 2-, 3-year overall survival (OS) for female patients with breast cancer liver metastasis (BCLM). HER2, Human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer.